LoginRegister
    Standard Chartered PE sells 1.41 percent stake in Fortis for Rs139 croreStandard Chartered PE sells 1.41 percent stake in Fortis for Rs139 crore
    Sebi slaps Rs 8 lakh fine on Aanjaneya Lifecares officialsSebi slaps Rs 8 lakh fine on Aanjaneya Lifecares officials
    PMs push for generic drugs to shift focus to chemists, says pharma industry bodyPM's push for generic drugs to shift focus to chemists, says pharma industry body
    Jubilant Life raises Rs 100 cr by issue of commercial papersJubilant Life raises Rs 100 cr by issue of commercial papers
    ED crackdown on Vasan Health Care, issues notice to Karti Chidambaram, Chennai health firmED crackdown on Vasan Health Care, issues notice to Karti Chidambaram, Chennai health firm
    Daiichi Objects Sale of Religare to Religare Health Insurance, moves to CourtDaiichi Objects Sale of Religare to Religare Health Insurance, moves to Court
    Online Pharmacy Netmeds to start 10 new Physical stores in ChennaiOnline Pharmacy Netmeds to start 10 new Physical stores in Chennai
    Credihealth receives Rs 10 Crore in Pre-series A FundingCredihealth receives Rs 10 Crore in Pre-series A Funding
    Abbott Lab to buy Alere for Whooping 4.48 billion dollarsAbbott Lab to buy Alere for Whooping 4.48 billion dollars
    RMS regrow get FDA India approval for Cell Therapy ProductRMS regrow get FDA India approval for Cell Therapy Product
    Cadila Healthcare achieves top third position in Pharmaceutical IndustryCadila Healthcare achieves top third position in Pharmaceutical Industry
    Dr Mohans Diabetes Specialties Centre receives Rs 66 Cr in Series A fundingDr Mohan's Diabetes Specialties Centre receives Rs 66 Cr in Series A funding
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X